BeOne Medicines Ltd. Cash & Short-Term Investments 2013-2026 | ONC
Beta
What is BeOne Medicines Ltd.'s current cash & short-term investments?
BeOne Medicines Ltd. (ONC) annual cash & short-term investments for 2025 was $4.55B, a 73.08% increase from 2024. BeOne Medicines Ltd. cash & short-term investments for the quarter ending March 31, 2026 was $4.79B.
What was BeOne Medicines Ltd.'s cash & short-term investments in 2024?
BeOne Medicines Ltd. annual cash & short-term investments for 2024 was $2.63B, a 17.60% decline from 2023.
What was BeOne Medicines Ltd.'s cash & short-term investments in 2023?
BeOne Medicines Ltd. annual cash & short-term investments for 2023 was $3.19B, a 29.69% decline from 2022.
What is BeOne Medicines Ltd.'s 5-year cash & short-term investments CAGR?
BeOne Medicines Ltd. cash & short-term investments grew at a compound annual growth rate (CAGR) of 0.48% from FY2020 to FY2025, going from $4.66B to $4.55B over 5 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-0.5%
FY2020
$4.66B
→
FY2025
$4.55B
13141516171819202122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.55B | +73.1% | 10-K |
| FY2024 | $2.63B | -17.6% | 10-K |
| FY2023 | $3.19B | -29.7% | 10-K |
| FY2022 | $4.53B | -31.5% | 10-K |
| FY2021 | $6.62B | +42.2% | 10-K |
| FY2020 | $4.66B | +372.7% | 10-K |
| FY2019 | $985.5M | -44.7% | 10-K |
| FY2018 | $1.78B | +112.7% | 10-K |
| FY2017 | $837.5M | +127.5% | 10-K |
| FY2016 | $368.2M | +266.4% | 10-K |
| FY2015 | $100.5M | +623.0% | 10-K |
| FY2014 | $13.9M | +254.0% | 10-K |
| FY2013 | $3.9M | - | 10-K |
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →